After sacrificing the mice, the FACS results showed that the percentage of GFP+ MLL-AF9 leukaemia cells in the BM, spleen, or peripheral blood was much higher in antibiotic-treated AML mice than in control PBS AML mice (Fig. 2c and Supplementary Fig. 2e). The gene discussed is KMT2A; the disease is acute myeloid leukemia.